Babylon (BBLN) Stock Forecast, Price Target & Predictions


OverviewOwnershipChart

BBLN Stock Forecast


Babylon stock forecast is as follows: a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.

BBLN Analyst Ratings


Buy

According to 1 Wall Street analysts, Babylon's rating consensus is 'Buy'. The analyst rating breakdown for BBLN stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Aug 17, 2022Canaccord GenuityBuyBuyHold
Row per page
Go to

Babylon's last stock rating was published by Canaccord Genuity on Aug 17, 2022. The company gave BBLN a "Buy" rating, the same as its previous rate.

Babylon Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
UTRSMinerva Surgical$0.01$5.0049900.00%Buy
HLTHCue Health$0.04$8.0019900.00%Hold
BBLNBabylon$0.55$5.50900.00%Buy
BEATHeartBeam$2.43$10.00311.52%Buy
NUTXNutex Health$23.04$45.0095.31%Buy
HCTIHealthcare Triangle$1.28$2.0056.25%Buy

BBLN Forecast FAQ


Yes, according to 1 Wall Street analysts, Babylon (BBLN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of BBLN's total ratings.